PFS
GSK icon

Prospera Financial Services’s GSK GSK Stock Holding History

Prospera Financial Services’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Sell
19,590
-35,184
-64% -$1.86M 0.01% 753
2026
Q1 		$3.02M Buy
54,774
+4,241
+8% +$230K 0.05% 388
2025
Q4 		$2.48M Buy
50,533
+34,428
+214% +$1.61M 0.04% 423
2025
Q3 		$695K Sell
16,105
-29,577
-65% -$1.16M 0.01% 819
2025
Q2 		$1.75M Buy
45,682
+29,175
+177% +$1.11M 0.03% 497
2025
Q1 		$639K Buy
16,507
+1,464
+10% +$53.6K 0.01% 694
2024
Q4 		$509K Sell
15,043
-2,838
-16% -$102K 0.01% 741
2024
Q3 		$731K Sell
17,881
-2,121
-11% -$86.8K 0.02% 603
2024
Q2 		$770K Buy
20,002
+3,677
+23% +$155K 0.02% 575
2024
Q1 		$700K Buy
16,325
+3,265
+25% +$135K 0.02% 597
2023
Q4 		$484K Sell
13,060
-1,041
-7% -$37.4K 0.02% 678
2023
Q3 		$511K Buy
14,101
+284
+2% +$10.1K 0.02% 607
2023
Q2 		$492K Buy
13,817
+306
+2% +$11K 0.02% 620
2023
Q1 		$481K Buy
13,511
+1,038
+8% +$36.3K 0.02% 622
2022
Q4 		$438K Buy
12,473
+4,513
+57% +$150K 0.02% 568
2022
Q3 		$235K Sell
7,960
-221
-3% -$8.38K 0.01% 733
2022
Q2 		$445K Sell
8,181
-1,496
-15% -$82.6K 0.02% 548
2022
Q1 		$527K Buy
9,677
+583
+6% +$31.7K 0.02% 584
2021
Q4 		$501K Buy
9,094
+1,167
+15% +$60.7K 0.02% 570
2021
Q3 		$379K Buy
7,927
+209
+3% +$10.5K 0.02% 603
2021
Q2 		$384K Buy
7,718
+811
+12% +$39K 0.02% 594
2021
Q1 		$308K Sell
6,907
-76
-1% -$3.45K 0.02% 608
2020
Q4 		$322K Buy
6,983
+4,684
+204% +$215K 0.02% 520
2020
Q3 		$108K Sell
2,299
-3,275
-59% -$164K 0.04% 385
2020
Q2 		$284K Sell
5,574
-603
-10% -$30.9K 0.03% 458
2020
Q1 		$293K Sell
6,177
-1,033
-14% -$55.1K 0.03% 398
2019
Q4 		$423K Buy
7,210
+1,878
+35% +$104K 0.03% 411
2019
Q3 		$284K Buy
5,332
+274
+5% +$14.1K 0.03% 448
2019
Q2 		$254K Buy
+5,058
New +$254K 0.03% 442
2017
Q4 		– Sell
-5,571
Closed -$284K – 417
2017
Q3 		$284K Sell
5,571
-1,239
-18% -$62.9K 0.04% 334
2017
Q2 		$363K Sell
6,810
-7,064
-51% -$377K 0.06% 273
2017
Q1 		$730K Sell
13,874
-1,184
-8% -$60.1K 0.13% 143
2016
Q4 		$735K Buy
15,058
+652
+5% +$32.2K 0.14% 129
2016
Q3 		$777K Buy
14,406
+216
+2% +$11.8K 0.16% 122
2016
Q2 		$769K Buy
14,190
+656
+5% +$34.6K 0.16% 119
2016
Q1 		$686K Buy
13,534
+5,104
+61% +$254K 0.15% 113
2015
Q4 		$425K Sell
8,430
-538
-6% -$27.4K 0.09% 148
2015
Q3 		$431K Buy
8,968
+1,162
+15% +$60.5K 0.11% 134
2015
Q2 		$406K Sell
7,806
-148
-2% -$8.33K 0.1% 156
2015
Q1 		$450K Sell
7,954
-169
-2% -$9.69K 0.1% 153
2014
Q4 		$434K Buy
8,123
+1,501
+23% +$84K 0.11% 148
2014
Q3 		$381K Buy
6,622
+2,392
+57% +$147K 0.1% 159
2014
Q2 		$283K Hold
4,230
– – 0.08% 200
2014
Q1 		$282K Buy
4,230
+1
+0% +$68 0.09% 178
2013
Q4 		$282K Sell
4,229
-289
-6% -$18.7K 0.09% 174
2013
Q3 		$286K Sell
4,518
-184
-4% -$11.8K 0.11% 161
2013
Q2 		$295K Buy
+4,702
New +$298K 0.14% 155

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Prospera Financial Services's GSK Position: Q2 2026 in Review

Prospera Financial Services reduced its GSK (GSK) stake by 64% in Q2 2026, selling an estimated $1.86M and leaving 19,590 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #753.

Prospera Financial Services first reported a position in GSK in Q2 2013 and has held it in 47 quarters since. The position peaked at $3.02M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Prospera Financial Services held 19,590 shares of GSK worth $1.03M as of Q2 2026.
  • Prospera Financial Services sold 35,184 GSK shares in Q2 2026, an estimated $1.86M.
  • GSK made up 0.01% of Prospera Financial Services's portfolio in Q2 2026, its #753 holding.
  • Prospera Financial Services first reported a position in GSK in Q2 2013 and has held it in 47 quarters since.
  • Prospera Financial Services's GSK position peaked at $3.02M in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.